Several medical professionals are pushing back against a recent claim made by Assistant Secretary of Health Rachel Levine, who announced that “there is no argument” about gender-affirming care among medical professionals who specialize in those under 18. They told Fox News that many of their colleagues fear speaking out publicly against transgender ideology over professional and personal retaliation anxieties. Medical professionals, including the Florida Department of Health, took issue with Levine’s allegation. [tweet_embed] May 14, 2022[/tweet_embed] In April, mentioning several peer-reviewed studies and a “lack of conclusive evidence, and the potential for long-term, irreversible effects,” Florida Surgeon General Joseph Ladapo issued a fact sheet advising against the HHS’s list of possible treatment options for young Americans with gender dysphoria. In an interview with NPR last month, Levine, who is a transgender female, announced: “there is no argument among medical professionals – pediatricians, pediatric endocrinologists, adolescent medicine physicians, adolescent psychiatrists, psychologists, etc. – about the value and the importance of gender-affirming care.” That HHS fact sheet said that “gender-affirming care” includes social affirmation, puberty blockers, and cross-sex hormone therapy starting in adolescence. It continues that irreversible surgery is “typically used in adulthood or case-by-case basis in adolescence” due to the agency. [tweet_embed] May 14, 2022[/tweet_embed] Ladapo’s office explained to Fox News that “the burden of proof to support the outlandish claims made on NPR falls on Dr. Levine.” Levine’s office confirmed the assistant secretary’s allegations when asked by Fox: “There is no debate in the medical community about the medical or scientific validity of gender-affirming care,” Levine’s communications director Adam Sarvana told Fox News. According to Fox News: “Sarvana said the standards of care from the World Professional Association for Transgender Health (WPATH) have been endorsed by multiple medical organizations, including the American Academy of Pediatrics (AAP), the American Medical Association (AMA), the American Psychiatric Association (APA) and the American Academy of Child & Adolescent Psychiatry (AACAP).” Idaho-based assistant clinical professor of endocrinology, Dr. William Malone, is a member of the Society for Evidence-Based Gender Medicine (SEGM). This international group of over 100 researchers and clinicians have expressed concerns about the “lack of quality evidence for the use of hormonal and surgical interventions as first-line treatment for young people with gender dysphoria.” [tweet_embed] May 14, 2022[/tweet_embed] This group issued a rebuttal of the HHS guidance on April 7, declaring that the department had failed to review available literature, and announced that they made biased recommendations without considering the possibility of alternative treatments, the low-quality evidence, or diversity of clinician viewpoints. Malone and many other colleagues composed a letter to the editor of The Journal of Clinical Endocrinology & Metabolism in March of 2021, in which they pointed out that the “standards of care” presented by WPATH and the ES are, in all actuality only practice guidelines, which are possibly subject to the bias of their sponsor, Fox News reported.